Literature DB >> 26027564

Graphene Oxide-Based Nanocarriers for Cancer Imaging and Drug Delivery.

Peihong You, Yang Yang, Mingwei Wang, Xiaoyu Huang, Xiao Huang1.   

Abstract

Nano graphene oxide (nGO) is a member of graphene family, which is a novel, one-atom-thickness, two-dimensional carbon nanomaterial. In comparison with graphene, nGO contains much higher extent of reactive chemical functionalities such as hydroxyl, carbonyl, carboxyl, and epoxy group, so as to enable its easier biochemo-functionalization, higher biocompatibility, and greater potentials of applications in biomedicine fields. Up to now, nGO has attracted extensive research interests in nanomedicine and drug delivery systems for cancer imaging and therapy due to its unique biochemical and in vivo properties. This review generally describes the preparation, functionalization, and toxicity of nGO firstly, and then focuses on the studies of biomedical applications for cancer imaging and drug delivery.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26027564     DOI: 10.2174/1381612821666150531170832

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  6 in total

Review 1.  Radio-graphene in Theranostic Perspectives.

Authors:  Do Won Hwang
Journal:  Nucl Med Mol Imaging       Date:  2016-03-18

Review 2.  Applications and toxicity of graphene family nanomaterials and their composites.

Authors:  Zorawar Singh
Journal:  Nanotechnol Sci Appl       Date:  2016-03-16

Review 3.  Mesoporous silica nanoparticles for stimuli-responsive controlled drug delivery: advances, challenges, and outlook.

Authors:  Yuanhui Song; Yihong Li; Qien Xu; Zhe Liu
Journal:  Int J Nanomedicine       Date:  2016-12-20

4.  Graphene Oxide and Reduced Graphene Oxide Exhibit Cardiotoxicity Through the Regulation of Lipid Peroxidation, Oxidative Stress, and Mitochondrial Dysfunction.

Authors:  Jian Zhang; Hong-Yan Cao; Ji-Qun Wang; Guo-Dong Wu; Lin Wang
Journal:  Front Cell Dev Biol       Date:  2021-03-18

Review 5.  The Role of Graphene Oxide Nanocarriers in Treating Gliomas.

Authors:  Bin Wang; Hanfei Guo; Haiyang Xu; Yong Chen; Gang Zhao; Hongquan Yu
Journal:  Front Oncol       Date:  2022-01-28       Impact factor: 6.244

6.  New generation of drug delivery systems based on ginsenoside Rh2-, Lysine- and Arginine-treated highly porous graphene for improving anticancer activity.

Authors:  Hadi Zare-Zardini; Asghar Taheri-Kafrani; Ahmad Amiri; Abdol-Khalegh Bordbar
Journal:  Sci Rep       Date:  2018-01-12       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.